2015 ICD-9-CM Diagnosis Code 258.02
Multiple endocrine neoplasia [MEN] type IIA
- ICD-9-CM 258.02 will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
- ICD-9-CM 258.02 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
- Multiple endocrine neoplasia type 2A
- Multiple endocrine neoplasia type 2A cancerous
- Multiple endocrine neoplasia type 2A noncancerous
- Multiple endocrine neoplasia type 2A, benign
- Multiple endocrine neoplasia type 2A, malignant
- Multiple endocrine neoplasia, type 2
- A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (carcinoma, medullary) of the thyroid gland, and usually with the co-occurrence of pheochromocytoma, producing calcitonin and adrenaline, respectively. Less frequently, it can occur with hyperplasia or adenoma of the parathyroid glands. This disease is due to gain-of-function mutations of the men2 gene on chromosome 10 (locus: 10q11.2), also known as the ret proto-oncogene that encodes a receptor protein-tyrosine kinase. It is an autosomal dominant inherited disease
- Multiple endocrine neoplasia caused by mutation of the ret gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia
Convert to ICD-10-CM
converts directly to:
- 2015 ICD-10-CM E31.22 Multiple endocrine neoplasia [MEN] type IIA